Labshake search
Citations for KeraFAST :
151 - 169 of 169 citations for Mouse Anti Herpes Simplex Virus 2 gD 0192 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... membranes were stained with Coomassie brilliant blue and then hybridized with an anti puromycin antibody (Kerafast, #EQ0001) to detect puromycinylated polypetides.
-
bioRxiv - Microbiology 2022Quote: ... Viral titer was evaluated as FFU/mL using the anti-VSV-Matrix protein 23H12 antibody (Kerafast Inc.) to detect infected cells.
-
bioRxiv - Microbiology 2019Quote: ... cells were incubated overnight at 4°C with anti-M2 monoclonal antibody (E10; catalog no. EMS009, Kerafast). Three washes were performed prior to addition of goat anti-mouse Alexa Fluor-647 secondary antibody (catalog no ...
-
bioRxiv - Microbiology 2021Quote: ... VSV M protein was detected using anti-VSV M antibody clone [23H12] (KeraFast, Boston, MA, Cat.# EB0011) at 1:1000 ...
-
bioRxiv - Cell Biology 2019Quote: ... blocked in 5% non-fat dry milk and incubated with the anti-DNA–RNA hybrid [S9.6] antibody (Kerafast) overnight at 4°C ...
-
bioRxiv - Immunology 2020Quote: ... and cells were washed with PBS before medium supplemented with anti-VSV-G antibody (clone 8G5F11, Kerafast Inc.) was added to neutralise residual input virus ...
-
bioRxiv - Neuroscience 2020Quote: ... and protein synthesis level was determined by Western blot using anti-puromycin antibody (KeraFAST, Cat#EQ0001, 1:1000). The combined intensity of proteins ranging from 20 to 200 kDa was quantified and normalized to the level of β-actin.
-
bioRxiv - Microbiology 2021Quote: ... The blocking solution was removed and replaced with fresh TBST containing 5% (w/v) milk and S9.6 anti-DNA-RNA Hybrid Antibody (Kerafast) at 1μg/ml and incubated at 4°C overnight ...
-
bioRxiv - Molecular Biology 2022Quote: ... Total cell lysates were generated and subjected to SDS-PAGE and immunoblot with an anti-puromycin antibody (Kerafast, EQ0001).
-
bioRxiv - Molecular Biology 2021Quote: ... while the lower portion of the membrane was probed with anti-VSV matrix protein antibody (Kerafast, EB0011; loading control) diluted 1:2,500 in 5% skim milk solution ...
-
bioRxiv - Microbiology 2021Quote: ... Cells were subsequently washed five times and supplied with fresh DMEM + 10% FBS medium + anti-VSV-G antibody (Kerafast). Cell-free supernatants were harvested at 24 h after transduction ...
-
bioRxiv - Immunology 2020Quote: ... after which medium was removed and cells were washed with PBS before complete medium supplemented with anti-VSV-G antibody (8G5F11, Kerafast) was added to the cells ...
-
bioRxiv - Cell Biology 2022Quote: ... blocked in 5% non-fat dry milk and incubated with the anti-DNA-RNA hybrid [S9.6] antibody (Kerafast, 1:1000) overnight at 4°C ...
-
bioRxiv - Immunology 2020Quote: ... the inoculum was removed and cells were washed with PBS before medium supplemented with anti-VSV-G antibody (clone 8G5F11, Kerafast Inc.) was added to neutralise residual input virus ...
-
bioRxiv - Microbiology 2020Quote: ... The denatured TCA-treated proteins were subjected to immunoblot analysis for VSV M and EBOV GP protein levels using anti-VSV M (1:2500, Kerafast, EB0011) and anti-EBOV GP (1:1000 ...
-
bioRxiv - Immunology 2022Quote: ... cells were washed twice with phosphate buffered saline (PBS) before medium supplemented with anti-VSV-G antibody (clone 8G5F11, Kerafast Inc.) was added to neutralize residual VSV-G-complemented input virus ...
-
bioRxiv - Immunology 2022Quote: ... cells were washed twice with phosphate buffered saline (PBS) before medium supplemented with anti-VSV-G antibody (clone 8G5F11, Kerafast Inc.) was added to neutralize residual VSV-G-complemented input virus ...
-
bioRxiv - Microbiology 2023Quote: ... After 1.5 h at 37°C cells were washed with PBS and incubated with DMEM containing 1 μg/ml anti-VSV-G antibody (Kerafast, EB0010) for 24 h at 37°C ...
-
bioRxiv - Molecular Biology 2023Quote: ... Media was replenished with DMEM+10%FBS containing a 1:20,000 dilution of an anti-VSV-G antibody 8G5F11 (Kerafast Cat. No EB0010), which reduces any possible background from residual VSV-G ...